137 related articles for article (PubMed ID: 21747743)
1. DedA protein relates to action-mechanism of halicyclamine A, a marine spongean macrocyclic alkaloid, as an anti-dormant mycobacterial substance.
Arai M; Liu L; Fujimoto T; Setiawan A; Kobayashi M
Mar Drugs; 2011; 9(6):984-993. PubMed ID: 21747743
[TBL] [Abstract][Full Text] [Related]
2. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent.
Arai M; Sobou M; Vilchéze C; Baughn A; Hashizume H; Pruksakorn P; Ishida S; Matsumoto M; Jacobs WR; Kobayashi M
Bioorg Med Chem; 2008 Jul; 16(14):6732-6. PubMed ID: 18556206
[TBL] [Abstract][Full Text] [Related]
3. Identification of the target protein of agelasine D, a marine sponge diterpene alkaloid, as an anti-dormant mycobacterial substance.
Arai M; Yamano Y; Setiawan A; Kobayashi M
Chembiochem; 2014 Jan; 15(1):117-23. PubMed ID: 24243718
[TBL] [Abstract][Full Text] [Related]
4. Action-mechanism of trichoderin A, an anti-dormant mycobacterial aminolipopeptide from marine sponge-derived Trichoderma sp.
Pruksakorn P; Arai M; Liu L; Moodley P; Jacobs WR; Kobayashi M
Biol Pharm Bull; 2011; 34(8):1287-90. PubMed ID: 21804219
[TBL] [Abstract][Full Text] [Related]
5. Haliclonacyclamines, tetracyclic alkylpiperidine alkaloids, as anti-dormant mycobacterial substances from a marine sponge of Haliclona sp.
Arai M; Ishida S; Setiawan A; Kobayashi M
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1136-8. PubMed ID: 19801875
[TBL] [Abstract][Full Text] [Related]
6. Aaptamines, marine spongean alkaloids, as anti-dormant mycobacterial substances.
Arai M; Han C; Yamano Y; Setiawan A; Kobayashi M
J Nat Med; 2014 Apr; 68(2):372-6. PubMed ID: 24414399
[TBL] [Abstract][Full Text] [Related]
7. Anti-dormant mycobacterial activity and target analysis of nybomycin produced by a marine-derived Streptomyces sp.
Arai M; Kamiya K; Pruksakorn P; Sumii Y; Kotoku N; Joubert JP; Moodley P; Han C; Shin D; Kobayashi M
Bioorg Med Chem; 2015 Jul; 23(13):3534-41. PubMed ID: 25934225
[TBL] [Abstract][Full Text] [Related]
8. Anti-mycobacterial alkaloids, cyclic 3-alkyl pyridinium dimers, from the Indonesian marine sponge Haliclona sp.
Maarisit W; Abdjul DB; Yamazaki H; Kato H; Rotinsulu H; Wewengkang DS; Sumilat DA; Kapojos MM; Ukai K; Namikoshi M
Bioorg Med Chem Lett; 2017 Aug; 27(15):3503-3506. PubMed ID: 28601525
[TBL] [Abstract][Full Text] [Related]
9. Neamphamide B, new cyclic depsipeptide, as an anti-dormant mycobacterial substance from a Japanese marine sponge of Neamphius sp.
Yamano Y; Arai M; Kobayashi M
Bioorg Med Chem Lett; 2012 Jul; 22(14):4877-81. PubMed ID: 22704240
[TBL] [Abstract][Full Text] [Related]
10. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.
Pruksakorn P; Arai M; Kotoku N; Vilchèze C; Baughn AD; Moodley P; Jacobs WR; Kobayashi M
Bioorg Med Chem Lett; 2010 Jun; 20(12):3658-63. PubMed ID: 20483615
[TBL] [Abstract][Full Text] [Related]
11. Concise access to a model of the marine alkaloid halicyclamine A through macrocycle-forming addition of a 5-aminopenta-2,4-dienal onto a 2,3-dihydropyridinium salt.
Sinigaglia I; Nguyen TM; Wypych JC; Delpech B; Marazano C
Chemistry; 2010 Mar; 16(12):3594-7. PubMed ID: 20191632
[No Abstract] [Full Text] [Related]
12. An anti-mycobacterial bisfunctionalized sphingolipid and new bromopyrrole alkaloid from the Indonesian marine sponge Agelas sp.
Abdjul DB; Yamazaki H; Kanno SI; Tomizawa A; Rotinsulu H; Wewengkang DS; Sumilat DA; Ukai K; Kapojos MM; Namikoshi M
J Nat Med; 2017 Jul; 71(3):531-536. PubMed ID: 28364227
[TBL] [Abstract][Full Text] [Related]
13. An Escherichia coli-Mycobacterium shuttle cosmid vector, pMSC1.
Hinshelwood S; Stoker NG
Gene; 1992 Jan; 110(1):115-8. PubMed ID: 1531970
[TBL] [Abstract][Full Text] [Related]
14. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis.
Bardarov S; Bardarov S; Pavelka MS; Sambandamurthy V; Larsen M; Tufariello J; Chan J; Hatfull G; Jacobs WR
Microbiology (Reading); 2002 Oct; 148(Pt 10):3007-3017. PubMed ID: 12368434
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
16. Detection of Mycobacterium bovis lymphocyte stimulating antigens in culture filtrates of a recombinant Mycobacterium smegmatis cosmid library.
Gormley E; Fray L; Sandall L; Ke G; Dupont C; Carpenter E
Vaccine; 1999 Jul; 17(22):2792-801. PubMed ID: 10438049
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis.
Cáceres NE; Harris NB; Wellehan JF; Feng Z; Kapur V; Barletta RG
J Bacteriol; 1997 Aug; 179(16):5046-55. PubMed ID: 9260945
[TBL] [Abstract][Full Text] [Related]
18. Solvolysis Artifacts: Leucettazoles as Cryptic Macrocyclic Alkaloid Dimers from a Southern Australian Marine Sponge,
Prasad P; Salim AA; Khushi S; Khalil ZG; Quezada M; Capon RJ
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30744132
[No Abstract] [Full Text] [Related]
19. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.
La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E
Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages.
Wei J; Dahl JL; Moulder JW; Roberts EA; O'Gaora P; Young DB; Friedman RL
J Bacteriol; 2000 Jan; 182(2):377-84. PubMed ID: 10629183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
